Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Signaling protein signature predicts clinical outcome of non-small-cell lung cancer

Fig. 3

Identification and validation of the 5-protein signature for squamous cell carcinoma (SCC). a The ROC curve of the SCC training set. The cutoff point of prognosis scores is shown. b-c Patients of the training set (b) and testing set (c) were classified into poor- and good-prognosis groups using the 5-protein SCC signature. The Kaplan-Meier estimates of overall survival for the two predicted prognosis groups are shown. d The prognosis score distribution, prognosis prediction using the signature, the three-year survival status and the expression profile of the 5-protein signature proteins were summarized on SCC patients of BJ cohort. Each column represents an individual patient. e SCC patients of the independent CQ validation cohort were classified into poor- and good-prognosis groups using the 5-protein SCC signature. The Kaplan-Meier survival curves for the two prognosis groups are shown. f Prognosis score distribution, prognosis prediction using the SCC protein signature, patient survival status and the expression profile of the 5-protein signature proteins of CQ SCC patients are shown

Back to article page